Beroni Group Inc (BNIGF:OTCQX) (ASX:BTG) CEO Jacky Zhang sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Australian-based company currently has four core businesses: research and development of new drugs and clinical trail, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.
